Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches

Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches

Abstract The exact cause of psoriasis is still unclear and there is no treatment available for its permanent reemission. The available biologics for disease treatment, are stated to be associated with a high cost of treatment, a significantly increased risk of serious infections, and have also been...

Full description

Saved in:
Bibliographic Details
Main Authors: Saumya Choudhary, Noor Saba Khan, Pallavi Saxena, Parameswar Sahu, Dibyabhaba Pradhan, Harpreet Singh, George Thomas, Neeraj Kumar
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Psoriasis
Drug repurposing
FDA approved drugs
Drug-target
Molecular docking and simulation
One-SVM algorithm
Online Access:https://doi.org/10.1038/s41598-025-01448-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-01448-7

Similar Items